ResMed makes CPAP systems, masks, diagnostic services and care software for sleep, breathing and home healthcare. It last closed at $237.95 on Nov 17, down 0.12% on the day. RMD reports earnings on Thu, Jan 28, 2027. The average 12-month price target from 4 analysts is $262.75 (+10.4% from the last close), with a high of $288.00 and a low of $236.00. Analyst consensus is Buy, based on the latest ratings from 4 firms (2 buy, 2 hold, 0 sell). Over the past 90 days StreetAlpha recorded 1 whale options trade in RMD, 0% of them bullish and 100% bearish. In the past 30 days there were 8 dark pool prints totaling $7.4M, the largest $2.2M.
Each firm's latest rating on RMD in the past 90 days
Average 12-month target
$262.75
▲ 10.4% upside
Based on 4 analysts who set a price target on RMD in the past 90 days. The average target is $262.75, with a high of $288.00 and a low of $236.00, compared with the last close of $237.95.
Low $236.00Avg $262.75High $288.00
Blue marker: last close $237.95
Highest target$288.00
Average target$262.75
Lowest target$236.00
Latest rating changes
RBC CapitalTarget raised
Oct 30Buy$262 → $288
Wells FargoTarget raised
Oct 30Hold$215 → $250
KeybancTarget raised
Oct 30Buy$267 → $277
NeedhamDowngrade
Sep 25Hold$236
RBC CapitalUpgrade
Sep 15Buy$244 → $262
Date
Firm
Action
Rating
Price target
Oct 30
RBC Capital
Target raised
Buy
$262 → $288
Oct 30
Wells Fargo
Target raised
Hold
$215 → $250
Oct 30
Keybanc
Target raised
Buy
$267 → $277
Sep 25
Needham
Downgrade
Hold
$236
Sep 15
RBC Capital
Upgrade
Buy
$244 → $262
Loading…
Technical Analysis
RMD · as of the Nov 17 close · updated after every close
Moving sideways
The stock sits between its 20 and 50 day averages. It is 6% above its 200 day average, so the longer trend is still up. Momentum is fading (RSI 51). The nearest support is the Pivot S1 at $235.91, and the nearest resistance the Pivot at $238.54.
Short trendNeutral
Long trendBullish
MomentumFading
StretchNormal
VolatilityHigh, 2.9%/day
Key levels
$277.6752 week high+16.7%
$242.40Swing high (Sep 1)+1.9%
$241.3620 day average+1.4%
$240.57Pivot R1+1.1%
$238.54Pivot+0.2%
$237.95Last close
$235.91Pivot S1−0.9%
$232.6950 day average−2.2%
$230.00Swing low (Nov 11)−3.3%
$224.19100 day average−5.8%
$223.69200 day average−6.0%
$180.2752 week low−24.2%
Indicators
RSI (14)
50.64
Middle of its range
Neutral
MACD
0.73
Below its signal line
Bearish
Stochastic
52.0
Middle of its range
Neutral
ADX (14)
23.1
Weak trend
Williams %R
-49.9
Oversold below −80, overbought above −20
Neutral
CCI (20)
-26.5
Oversold below −100, overbought above 100
Neutral
Rate of change
+4.8%
Change over 10 sessions
Bullish
ATR (14)
$6.92
Typical daily range, 2.9% of price
MA 10Above
MA 20Below
MA 50Above
MA 100Above
MA 200Above
Rising
Short trendBullish
Long trendNot enough history
MomentumStrong
StretchNormal
VolatilityNormal, 6.3%/day
Key levels
$277.6752 week high+16.7%
$242.40Swing high (Sep 1)+1.9%
$241.3620 day average+1.4%
$240.57Pivot R1+1.1%
$238.54Pivot+0.2%
$237.95Last close
$235.91Pivot S1−0.9%
$232.6950 day average−2.2%
$230.00Swing low (Nov 11)−3.3%
$224.19100 day average−5.8%
$223.69200 day average−6.0%
$180.2752 week low−24.2%
Indicators
RSI (14)
55.14
Middle of its range
Neutral
MACD
4.86
Above its signal line
Bullish
Stochastic
60.7
Middle of its range
Neutral
ADX (14)
20.5
Weak trend
Williams %R
-44.3
Oversold below −80, overbought above −20
Neutral
CCI (20)
85.4
Oversold below −100, overbought above 100
Neutral
Rate of change
+9.0%
Change over 10 sessions
Bullish
ATR (14)
$14.97
Typical daily range, 6.3% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Below
MA 200–
What happened before, for RMD
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how RMD did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
November seasonalityHow RMD usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How RMD has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2006.
For membersMonth by month buying, shares and the average price paid each month are shown to AI Starter and AI Pro members.
From the company's 10-Q filed Oct 30, 2026. Quarters are the company's own fiscal quarters. Yield and % of value use the latest close. Buybacks are not a forecast: in our testing, the biggest buyers did about the same as the average S&P 500 stock.
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether RMD is in one of them and how their past RMD trades turned out.
Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.
About Resmed
ResMed is a medical device and software company based in San Diego, California. Its main products are CPAP systems and masks that treat sleep apnea and other breathing disorders, along with diagnostic testing services and connected tools that help clinicians and patients manage therapy. The company also sells software to residential care providers and home medical equipment suppliers. Its customers include patients, physicians, and care providers in many countries.